University of Thessaly (UTH)
Η μελέτη της φυσικής ιστορίας της πρωτοπαθούς χολικής κίρρωσης
Abstract
dc:descriptionPrimary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease which can lead to end-stage liver disease if left untreated. Over recent decades, the epidemiology and natural history of the disease have evolved, with patients being diagnosed at an older age and at earlier stages of the disease, alongside the emergence of new therapeutic options. The aim of the present study was to analyze patients’ and disease’s characteristics in a large cohort of PBC patients from Greece and to investigate factors associated with disease progression and adverse outcomes. This retrospective analysis utilized prospectively collected data from 860 well-characterized PBC patients at our center. Females constituted 85.2% of the cohort, with a mean age at diagnosis of 56±14 years and a median follow-up duration of 5 (0.5-22) years. At diagnosis, 52% of the patients were symptomatic, while 15.6% had established cirrhosis, nearly half of whom experienced decompensation. Anti- mitochondrial antibodies (AMA) were detected in 97.6% (839/860) of patients, whereas antinuclear (ANA) – PBC specific autoantibodies (anti-gp210 and/or anti-sp100), were present in 16.3% (140/860). Patients positive for ANA were older and exhibited a more active disease, including elevated AST, ALT, γGT, IgM levels, and lower albumin. Urso-deoxycholic acid (UDCA) was administered to 89.4% (769/860) of patients. Treatment response was assessed using the Paris II criteria and the GLOBE score, with complete response rates of 75.9% and 68.9%, respectively. Patients positive for anti-sp100 demonstrated reduced response to UDCA therapy based on the GLOBE score (p=0.05). Second-line therapies were applied in 7% of cases.At the final evaluation, 7.1% (61/860) of patients had either died from liver-related causes or undergone liver transplantation. Multivariate analysis identified older age, presence of cirrhosis at diagnosis, coexistence of other liver diseases, and non-response to therapy as factors associated with worse outcome (p<0.05). During follow-up 5.1% (44/860) of patients experienced disease progression (including cirrhosis development, decompensation of cirrhosis, or hepatocellular carcinoma occurrence). Factors associated with disease progression included older age, non-response to therapy and cirrhosis at diagnosis (p<0.05). This study of the natural history of PBC in a large Greek cohort with long-term follow-up confirms that older age at diagnosis and lack of response to treatment are significant predictors of poor prognosis. Early identification of these patients is crucial to ensure close monitoring and timely initiation of second-line therapies to prevent disease progression.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lygoura, Vasiliki
- Λυγούρα, Βασιλική
Subjects
dc:subject × 21- Πρωτοπαθή χολική χολαγγειίτιδα
- Φυσική ιστορία
- Χολόσταση
- Αρκτοδεσοξυχολικό οξύ
- Κίρρωση
- Primary billiary cirrhosis
- Natural history
- Ursodeoxycholic acid (UDCA)
- Cirrhosis
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιδημιολογία
- Επιστήμες υγείας, γενικά
- Κλινική Ιατρική
- Ηπατολογία
- Health Sciences
- Medical and Health Sciences
- Epidemiology
- Health sciences, general
- Clinical Medicine
- Hepatology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61519